Screener
Collegium Pharmaceutical, Inc. COLL Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 60%+3.3pp | 60.7%+3.0pp | 59.3%-0.4pp | 57.2%-5.1pp | 56.7%-5.3pp | |
| Operating margin | 19.5%+1.1pp | 23.7%+2.3pp | 23%-3.9pp | 20.7%-11.5pp | 18.4%-17.0pp | |
| Net margin | 5.9%+0.8pp | 9.4%+2.8pp | 8.1%-2.9pp | 7.7%-7.1pp | 5.1%-12.2pp | |
| Returns | ||||||
| Return on equity | 17.6%+1.4pp | 27.4%+8.2pp | 23.7%-8.9pp | 23%-19.9pp | 16.2%-31.7pp | |
| Return on invested capital | 72.8%-45.2pp | 172.1%+17.8pp | 125.6%— | 68.1%— | 118%— | |
| Efficiency | ||||||
| Asset turnover | 0.4×-0.1× | 0.5×0.0× | 0.5×0.0× | 0.5×0.0× | 0.5×0.0× | |
| Liquidity | ||||||
| Current ratio | 1×-0.2× | 1.7×+0.6× | 1.6×+0.6× | 1.4×+0.4× | 1.2×+0.1× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Net debt / EBITDA | -0.5×-0.1× | -0.9×-0.6× | -0.8×-0.6× | -0.4×-0.3× | -0.4×+0.1× | |
| Per Share | ||||||
| Book value per share | $9.61+61.7% | $7.80+9.2% | $7.53+31.9% | $6.97+19.5% | $5.94+10.8% | |
| Valuation | ||||||
| Market capitalization | $944.15M-1.3% | $1.05B+9.5% | $1.46B+58.4% | $1.1B-11.4% | $967.8M-8.1% | |
| Price / earnings | 19.7×-6.7× | 14×-7.8× | 23.3×+9.9× | 18.9×+4.8× | 26.7×+16.1× | |
| Price / sales | 1.2×-0.2× | 1.3×-0.1× | 1.9×+0.4× | 1.5×-0.6× | 1.4×-0.5× | |
| Price / book | 3×-1.1× | 3.4×-0.7× | 4.9×+0.8× | 4×-1.3× | 4.2×-0.7× | |
| EV / EBITDA | 2.9×+0.4× | 2.5×0.0× | 4.1×+1.7× | 2.9×-0.6× | 2.4×-0.1× |
FAQ
- What are Collegium Pharmaceutical, Inc.'s profit margins?
- Collegium Pharmaceutical, Inc. (COLL) runs a 60.0% gross margin and a 19.5% operating margin, with a 5.9% net margin.
- Where do Collegium Pharmaceutical, Inc.'s ratios come from?
- Every ratio is computed from Collegium Pharmaceutical, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
